Single Cell Analysis Market by Product, Technology, Process, Application, End-User

List of Tables

[186 Pages Report] The Single Cell Analysis Market size was estimated at USD 6.26 billion in 2023 and expected to reach USD 6.93 billion in 2024, at a CAGR 10.99% to reach USD 12.99 billion by 2030.

Single cell analysis (SCA) refers to the study and characterization of individual cells to uncover functional, morphological, and molecular differences that contribute to cellular heterogeneity within tissues and organs. This advanced technology enables scientists to understand the complex biological processes at the single-cell level, providing insights that were previously obscured in analyses of cell populations. By examining cells individually, researchers can dissect the cellular mechanisms behind diseases, personalize medicine, and enhance the development of therapies by pinpointing the cellular makeup of a patient's condition. The growing emphasis on personalized medicine, coupled with technological advancements in single-cell genomics and proteomics, is a primary driver for the single cell analysis market. Increased investments in research and development by biotechnology and pharmaceutical companies to understand disease heterogeneity and to identify novel drug targets have also significantly propelled the demand for single cell analysis techniques. Despite its potential, single cell analysis faces several obstacles owing to the complexity of obtaining, isolating, and preserving individual cells without causing damage poses technical challenges. High costs associated with specialized equipment and reagents can also limit the widespread accessibility of single cell analysis. However, the potential to revolutionize the field of oncology by enabling the understanding of tumoral heterogeneity and the development of targeted treatments presents a lucrative scope for the single cell analysis market. The increasing volume of collaborative efforts in biomedical research and the integration of artificial intelligence to manage and interpret complex datasets have opened new avenues for discoveries and innovations in single-cell technologies, representing a promising frontier in precision medicine.

KEY MARKET STATISTICS
Base Year [2023]	USD 6.26 billion
Estimated Year [2024]	USD 6.93 billion
Forecast Year [2030]	USD 12.99 billion
CAGR (%)	10.99%

Product: Significance of automated cell counters and microscopes for rapid and efficient assessment of cells

Consumables within the realm of single cell analysis, such as assay kits and reagents, are critical in conducting precise and reliable experiments. Assay kits are designed to provide all necessary components for specific single-cell assays, allowing for the exploration of cellular heterogeneity, gene expression, and cellular function at the individual cell level. Reagents are the chemical solutions and substances that react with the single cell or its components to facilitate detection, measurement, or manipulation, ensuring the accuracy and reproducibility of data across various experiments. In the sphere of single cell analysis, instruments are crucial for collecting and analyzing data. Automated cell counters enable rapid and efficient counting of cells in a sample with minimal user intervention, while cell microarrays provide a platform for detailed analysis of single cells in a highly controlled environment. Flow cytometers are indispensable for quantifying the physical and chemical characteristics of cells in a fluid stream. Hemocytometers offer a traditional manual counting method using a microscopic grid. High-content screening systems automate the image capture and analysis of cells, enabling large-scale functional analysis. Microscopes allow for detailed visual inspection and imaging of individual cells. PCR systems amplify specific DNA sequences from a single cell, enabling genetic analysis.

End-User: Growing adoption of single cell analysis in biotechnology and pharmaceutical companies to develop tailored treatments

Academic and research laboratories represent crucial end-users in the single cell analysis market. They leverage these advanced analytical techniques to dissect cellular heterogeneity, understand cellular dynamics, and drive innovations in basic biological research. These entities are often at the forefront of method development in single-cell genomics, transcriptomics, and other omics areas, providing vital insights into complex biological systems and disease mechanisms that can inform future therapeutic strategies. Biotechnology and pharmaceutical companies utilize single cell analysis technologies for various applications, including drug discovery, personalized medicine, and therapeutic development. By analyzing cells at an individual level, these companies can uncover unique biomarkers, explore cellular responses to drugs, and enable high-resolution mapping of disease progression, thereby accelerating the path from research to clinical application and tailoring treatments to patient-specific profiles. Cell banks and in vitro fertilization (IVF) centers are increasingly adopting single cell analysis to improve the understanding and outcomes of reproductive technologies. Through single cell analysis, these centers can assess the viability and genetic health of gametes and embryos, enhancing the success rates of IVF procedures. Additionally, such detailed analysis supports the quality control processes in stem cell banking by ensuring the purity and pluripotency of stored cells. Hospitals and diagnostic laboratories are integral end-users of single cell analysis, using it to advance clinical diagnostics and patient care. They employ single cell techniques to dissect the molecular basis of diseases at the level of individual cells, providing detailed diagnostic information that can guide treatment decisions. This high-resolution approach is particularly impactful in areas such as oncology, where understanding tumor heterogeneity is key to effective treatment regimens and predicting patient response to therapies.

Regional Insights

In the Americas, the market for single cell analysis is robust, driven by a strong research environment, substantial investments in healthcare, and the presence of established biotech and pharmaceutical companies. Precision medicine initiatives and the adoption of personalized therapies are further propelling the growth of the single cell analysis market in this region. The EMEA region shows a positive market landscape within the single cell analysis landscape, attributable primarily to the diverse and sophisticated healthcare systems found particularly in Europe. There is a growing emphasis on research and development, especially in the biotechnology and pharmaceutical sectors. Factors such as the rise in cancer prevalence and the growing elderly population underpin the need for single cell analysis technologies in the region. The stringent regulatory environment also ensures that novel and reliable technologies gain traction in the EMEA market, contributing to overall growth. The Asia-Pacific is experiencing rapid growth in the single cell analysis market owing to increasing healthcare expenditures, rising awareness about advanced medical diagnostics, and burgeoning pharmaceutical and biotech industries. The increasing prevalence of chronic diseases and the expanding middle class are other crucial factors that lead to the higher adoption of single cell analysis in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Single Cell Analysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Single Cell Analysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Single Cell Analysis Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Becton, Dickinson and Company, BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., bioMerieux SA, Corning Incorporated, Danaher Corporation, Diasorin S.p.A., General Electric Company, Illumina, Inc., LumaCyte, Inc., MedGenome Inc., Menarini Group, Merck KGaA, Novogene Co., Ltd., Oxford Nanopore Technologies PLC, PerkinElmer Inc., Promega Corporation, QIAGEN N.V., Sartorius AG, Standard BioTools Inc., Takara Bio Inc., and Thermo Fisher Scientific, Inc..

Market Segmentation & Coverage

This research report categorizes the Single Cell Analysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Consumables
  - Assay Kits
  - Reagents

Instruments
- Automated Cell Counters
- Cell Microarrays
- Flow cytometers
- Hemocytometers
- High-content Screening System
- Microscopes
- PCR Systems

Technology
- Flow Cytometry
- Mass Spectrometry
- Microscopy
- Next-generation Sequencing
- Polymerase Chain Reaction

Process
- Single Cell Genomics
- Single Cell Proteomics
- Single Cell Transcriptomics

Application
- Cancer
- Immunology
- In-vitro Fertilization
- Neurology
- Non-invasive Prenatal Diagnosis
- Stem Cell

End-User
- Academic & Research Laboratories
- Biotechnology and Pharmaceutical Companies
- Cell Banks & IVF Centers
- Hospitals and Diagnostic Laboratories

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Single Cell Analysis Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Single Cell Analysis Market?

3. What are the technology trends and regulatory frameworks in the Single Cell Analysis Market?

4. What is the market share of the leading vendors in the Single Cell Analysis Market?

5. Which modes and strategic moves are suitable for entering the Single Cell Analysis Market?

Product Code: MRR-A339DAEFA8C2

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increase in the Number of Chronic Diseases Worldwide
  - 5.1.1.2. Increasing Application of Single-Cell Analysis in Cancer Research
  - 5.1.1.3. Rising Investment and Funding from Government, Pharmaceutical and Biopharmaceutical Companies for Cell-Based Research
- 5.1.2. Restraints
  - 5.1.2.1. High Cost of Single-Cell Analysis Products
- 5.1.3. Opportunities
  - 5.1.3.1. Emerging Demand for Single-Cell Analysis in Stem Cell Research and scRNA-seq in Precision Medicine
  - 5.1.3.2. Rising Popularity of Single-Cell Genomics and Proteomics
- 5.1.4. Challenges
  - 5.1.4.1. Challenge in Effective Data Analysis
5.2. Market Segmentation Analysis
- 5.2.1. Product: Significance of automated cell counters and microscopes for rapid and efficient assessment of cells
- 5.2.2. End-User: Growing adoption of single cell analysis in biotechnology and pharmaceutical companies to develop tailored treatments
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization

6. Single Cell Analysis Market, by Product

6.1. Introduction
6.2. Consumables
6.3. Instruments

7. Single Cell Analysis Market, by Technology

7.1. Introduction
7.2. Flow Cytometry
7.3. Mass Spectrometry
7.4. Microscopy
7.5. Next-generation Sequencing
7.6. Polymerase Chain Reaction

8. Single Cell Analysis Market, by Process

8.1. Introduction
8.2. Single Cell Genomics
8.3. Single Cell Proteomics
8.4. Single Cell Transcriptomics

9. Single Cell Analysis Market, by Application

9.1. Introduction
9.2. Cancer
9.3. Immunology
9.4. In-vitro Fertilization
9.5. Neurology
9.6. Non-invasive Prenatal Diagnosis
9.7. Stem Cell

10. Single Cell Analysis Market, by End-User

10.1. Introduction
10.2. Academic & Research Laboratories
10.3. Biotechnology and Pharmaceutical Companies
10.4. Cell Banks & IVF Centers
10.5. Hospitals and Diagnostic Laboratories

11. Americas Single Cell Analysis Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Single Cell Analysis Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Single Cell Analysis Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. Market Share Analysis, 2023
14.2. FPNV Positioning Matrix, 2023
14.3. Competitive Scenario Analysis
- 14.3.1. Singleron launches the AccuraSCOPE(R) Single Cell Transcriptome
- 14.3.2. Mitsui Chemicals Invests in Zafrens, a High-Throughput Single-Cell Analysis and Drug Discovery Company
- 14.3.3. Deepcell Launches AI-Powered Single Cell Analysis Platform

15. Competitive Portfolio

15.1. Key Company Profiles
15.2. Key Product Portfolio